Table 3:
Baseline STI positivity | STI incidence | |
---|---|---|
PAR% (95% CI) | PAR% (95% CI) | |
Age at sexual debut | 22% (16%, 28%) | 29% (22%, 38%) |
<15 years | 2% (1%, 4%) | 3% (2%, 5%) |
15-19 years | 20% (16%, 28%) | 26% (19%, 34%) |
single/not cohabiting | 12% (10%, 15%) | 32% (29%, 35%) |
2 or more sex partners1 | 4% (3%, 5%) | 7% (6%, 8%) |
Parity categories | 20% (17%, 23%) | 23% (21%, 25%) |
Nil | 4% (02%, 5%) | 4% (3%, 5%) |
1 to 2 children | 16% (14%, 19%) | 19% (17%, 21%) |
Injectable contraceptives | 3% (2%, 5%) | 18% (16%, 20%) |
STI baseline | - | 25% (23%, 27%) |
Combined impacts #1 | 51% (47%, 58%) | 53% (49%, 59%) |
Age at sexual debut + Single/not cohabiting + two or more sex partners + parity <3 |
Age at sexual debut + Single/not cohabiting + two or more sex partners + parity <3 |
|
Combined impacts #2 | N/A | 59% (49%, 64%) |
Age at sexual debut + Single/not cohabiting + two or more sex partners + parity <3 + injectables + STI baseline |
past 3 months;
N/A: not applicable